Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cureus
A systematic review of five studies found no consistent short-term safety signals in renal, hepatic, or cardiometabolic outcomes among adolescents using creatine monohydrate.
Cardiology May 7th 2026
Conexiant
A post hoc SURPASS-CVOT analysis associated tirzepatide with fewer six-component cardiorenal events than dulaglutide in patients with type 2 diabetes and established ASCVD.
Cardiology May 5th 2026
Mayo Clinic Labs
Hereditary TTP, an ultra-rare ADAMTS13 deficiency affecting roughly one in a million, is now managed with weekly recombinant ADAMTS13 infusions in a pediatric outpatient setting.
Hematology April 28th 2026
Medical News Today (MNT)
According to the Gould Registry, in 5,006 patients with ASCVD, only one in three patients had LDL cholesterol even less than 70mg/dl.
Cardiology April 10th 2026
Heart
Studies on fluid restriction in patients with HF are scarce, and most of the available studies are at high risk of bias. Although power is lacking, there is no evidence indicating that fluid restriction affects mortality or HF hospitalizations, but there is a signal of harm in terms of thirst distress.
Cardiology March 25th 2026
The researchers discovered that findings among older adults reinforced the guideline shift toward personalized, risk-based care.